Mark Atkinson
Professor
Department of Pathology, Immunology and Laboratory Medicine 
University of Florida College of Medicine 
Gainesville, Florida  

Publications
  1. *Atkinson, M.A.; Maclaren, N.K.; Riley, W.J.; Winter, W.E.; Fisk, D.D.; and Spillar, R.P.:  Are Insulin Autoantibodies, Markers for Insulin?Dependent Diabetes Mellitus? Diabetes 35, 1986, pp. 894-898.
  2. *Beppu, H.; Winter, W.E.; Atkinson, M.A.; Maclaren, N.K.; Fujita, K.; and Takahashi, H.: Bovine Albumin Antibodies in NOD Mice. Diabetes Research 6, 1987, pp. 67-69.
  3. *Maclaren, N.; Riley, W.; Skordis, N.; Atkinson, M.; Spillar, R.; Silverstein, J.; Klein, R.; and Rotter, J.: Inherited Susceptibility to Insulin Dependent Diabetes is Associated with HLA-DR 1, While DR5 is Protective. Autoimmunity 1, 1988, pp. 197-205.
  4. *Atkinson, M.A.; and Maclaren, N.K.: Autoantibodies in Non-Obese Diabetic Mice Immunoprecipitate an Mr 64,000 Islet Cell Antigen. Diabetes 37, 1988, pp. 1587-1590.
  5. *Atkinson, M.A.; Winter, W.E.; Skordis, N.K.; Beppu, H.; Riley, W.J.; and Maclaren, N.K.: The Effect of Diet on the Prevalence and Onset of Insulin Dependent Diabetes in the BB Rat. Autoimmunity 2, 1988, pp. 11-20. 
  6. *Riley, W.J.; Atkinson, M.A.; Schatz, D.A.; Maclaren, N.K.: Comparison of Islet Autoantibodies in "Pre-diabetes" and Recommendations for Screening. The Journal of Autoimmunity 3, 1990, pp. 47-52.
  7. *Atkinson, M.A.; Maclaren, N.K.; Holmes, L.A.; Scharp, D.W.; Lacy, P.E.; and Riley, W.J.: The Natural History and Predictive Value of Mr 64,000 Autoantibodies for Insulin Dependent Diabetes. The Journal of Autoimmunity 3, 1990, pp. 41-46.
  8. *Atkinson, M.A.; Maclaren, N.K.; Riley, W.J.; Scharp, D.W.; and Lacy, P.E.:  Mr 64,000 Autoantibodies as Predictors of Insulin Dependent Diabetes. The Lancet 335, 1990, pp. 1357-1360.
  9. Atkinson, M.A.; and Maclaren, N.K.: What Causes Diabetes?  Scientific American July 1990, pp. 62-67.
  10. *Atkinson, M.A.; N.K. Maclaren; Luchetta, R.; and Burr, I.: Prophylactic insulin therapy prevents Insulitis and Insulin Dependent Diabetes in Non-Obese Diabetic Mice. Diabetes 39, 1990, pp. 933-937.
  11. *Atkinson, M.A.; Maclaren, N.K.; and Scharp, D.W.: No Evidence for HSP 65 in Insulin Dependent Diabetes. The Lancet 336, 1990, pp. 1250-1251.
  12. *Atkinson, M.A.; Holmes, L.A.; Sharp, D.W.; Lacy, P.E.; and Maclaren, N.K.: No Evidence for Serological Autoimmunity Toward Islet Cell Heat Shock Proteins in Insulin Dependent Diabetes. The Journal of Clinical Investigation 87, 1991, pp. 721-724.
  13. *Kaufman, D.L.; Erlander, M.G.; Clare-Salzler, M.C.; Atkinson, M.A.; Maclaren, N.K.; and Tobin, A.J.: Autoimmunity to two forms of Glutamate Decarboxylase in Insulin Dependent Diabetes. The Journal of Clinical Investigation 89, 1992, pp. 283-292.
  14. *Atkinson, M.A.; Kaufman, D.L.; Campbell, L.; Gibbs, K.A.; Shah, S.C.; Bu, D.F.; Erlander, M.G.; Tobin, A.J.; and Maclaren, N.K.:  Peripheral Blood Mononuclear Cells Respond to Glutamate Decarboxylase in Insulin Dependent Diabetes. The Lancet 339, 1992, pp. 548-549.
  15. Maclaren, N.K.; and Atkinson, M.A.: Is Insulin Dependent Diabetes Environmentally Induced? The New England Journal of Medicine  327, 1992, pp.348-349.
  16. *Atkinson, M.A.; Kaufman, D.L.; Tobin, A.J.; and Maclaren, N.K.: Islet Cell Autoantibodies Reactive to Glutamate Decarboxylase in Insulin Dependent Diabetes. The Journal of Clinical Investigation.  91, 1992, pp. 350-356.
  17. *Atkinson, M.A.; and Maclaren, N.K.: Islet Cell Autoantigens  Diabetes Reviews 1: 1993, pp. 191-203.
  18. *Huang, L.; Atkinson, M.A.; Dush, P.; and Kennedy, R.T.: Amperometric Monitoring of Individual Exocytosis Events in Pancreatic Beta Cells.  Analytical Chemistry  65, 1993, pp. 1882-1887.
  19. *Atkinson, M.A.; and Maclaren, N.K.:  Islet Cell Autoantigens in Insulin Dependent Diabetes. The Journal of Clinical Investigation 92: 1993, pp. 1608-1616.
  20. *Kaufman, D.L.; Clare-Salzler, M.C.; Sercarz, E.E.; Tobin, A.J.; Atkinson, M.A.; and Lehmann, P.: Spontaneous Loss of Self Tolerance to Glutamate Decarboxylase is a Key Event in the Pathogenesis of Murine Insulin-Dependent Diabetes. Nature 366: 1993, pp. 69-71.
  21. *Atkinson, M.A.; Bowman, M.A.; Kao, K.J.; Campbell, L.; Dush, P.J.; Simmel, O.; and Maclaren, N.K.: Lack of Immune Responses to Bovine Serum Albumin in Insulin Dependent Diabetes. The New England Journal of Medicine 329, 1993, pp. 1853-1858.
  22. *Bowman, M.A.; Leiter, E.H.; and Atkinson, M.A.: Prevention of Diabetes in the NOD Mouse: Implications for Therapeutic Intervention in Human Disease.  Immunology Today 15, 1994, pp. 115-120.
  23. Atkinson, M.A.; Kao, K.J.; and Maclaren, N.K.: Lack of Immunity to Bovine Serum Albumin in Insulin Dependent Diabetes. The New England Journal of Medicine 330, 1994, pp. 1616-1617.
  24. Leslie, R.D.G.;  and Atkinson, M.A.: Inverse Relation Between Humoral and Cellular Immunity to Glutamic Acid Decarboxylase in Insulin Dependent Diabetes.  The Journal of Endocrinological Investigation  17, 1994, pp.581-584
  25. *Atkinson, M.A.; Bowman, M.A.; Campbell, L.; Kaufman, D.L.; and Maclaren, N.K.: Cellular Immunity to a Determinant Common to Glutamate Decarboxylase and Coxsackie Virus in Insulin Dependent Diabetes. The Journal of Clinical Investigation 94, 1994, pp. 2125-2129.
  26. *Atkinson, M.A.; and Maclaren, N.K.:  The Pathogenesis of Insulin Dependent Diabetes. The New England Journal of Medicine  331, 1994, pp. 1428-1436.
  27. *Gerling, I.; Atkinson, M.A.; Leiter, E.H.:  The Thymus as a Site for Evaluating the Potency of Candidate b Cell Autoantigens in NOD mice. The Journal of Autoimmunity  7, 1994, pp. 851-858.
  28. *Schott, M.; Schatz, D.; Atkinson, M.; Krischer, J.; Mehta, H.; Vold, B.; Maclaren, N.: GAD65 Autoantibodies Increase the Predictability but not the Sensitivity of Islet Cell and Insulin Autoantibodies for Developing Insulin Dependent Diabetes Mellitus.  The Journal of Autoimmunity 7, 1994, pp. 865-872.
  29. Atkinson, M.A.; and Ellis, T.M.: Should We Replace Islet Cell Antibody Assay For The Prediction of Insulin Dependent Diabetes. Diabetes Prevention & Therapy 8, 1994, pp. 33-34.
  30. *Hanson, M.S.; Serreze, D.V.; and Atkinson, M.A. et al: Clonal Diversion of T Cell Responses from Th1 to Th2: A Possible Mechanism of Diabetes Resistance in NOD-EadTransgenic Mice.  Autoimmunity 21, 1995, pp. 52-56.
  31. Atkinson, M.A.; and Schatz, D.S.: Cow’s Milk and IDDM: Only Time Will Tell. Diabetes Prevention & Therapy  9, 1995, pp. 1-2.
  32. *Huang, L.; Shen, H.; Atkinson, M.A.; and Kennedy, R.T.: Detection of Exocytosis At Individual Pancreatic b cells by Amperometry at a Chemically Modified Microelectrode.   Proceedings of The National Academy of Sciences, USA  92, 1995, pp. 9608-9612. 
  33. *Daw, K.; Ujihara, N.; Atkinson, M.A.; Powers, A.C.: Glutamic Acid Decarboxylase Autoantibodies in Stiff-Man Syndrome and Insulin Dependent Diabetes Mellitus Exhibit Similarities and Differences in Epitope Recognition. The Journal of Immunology  156, 1996, pp. 818-825.
  34. *Ellis, T.M.; and Atkinson, M.A.: The Clinical Significance of an Autoimmune Responses against Glutamic Acid Decarboxylase. Nature Medicine 2, 1996, pp.148-153.
  35. *Bowman, M.A.; Campbell, L.; Darrow, B.; Suresh, A.; Clare-Salzler, M.; and Atkinson, M.A.: Immunologic and Metabolic Effects of Prophylactic Insulin Therapy in Insulin Dependent Diabetes. Diabetes 45, 1996, pp. 205-208.
  36. *Tian, J.; Atkinson, M.A.; Clare-Salzler, M.; Herschenfeld, A.; Forsthuber, T.; Lehmann, P.V.; and Kaufman, D.L.: Nasal Administration of Glutamate Decarboxylase (GAD 65) Peptides Induces Th2 Responses and Prevents Murine Insulin-Dependent Diabetes. The Journal of Experimental Medicine 183, 1996, pp. 1561-1567.
  37. *Ellis, T.M.; and Atkinson, M.A.: Early Infant Diets and Insulin Dependent Diabetes. The Lancet  347, 1996, pp. 1464-1465.
  38. *Aanstoot, H.J.; Kim, J.; Knip, M.; Atkinson, M.A.; Mose-Larsen, P.; Fey, S.; Fu, Q.; Ludvigsson, J.; Landin, M.; Bruining, J.; Maclaren, N.K.; Akerblom, H.K.; and Baekkeskov, S.: Identification and Characterization of a 38kD pancreatic B-cell antigen which along with glutamic acid decarboxylase marks the early phases of autoimmune response in type 1 diabetes.  The Journal of Clinical  Investigation 97, 1996, pp. 2772-2783.
  39. *Hanson, M.S.; Cetkovic-Cvrlje, M.; Ramiya, V.K.; Atkinson, M.A.; Maclaren, N.K.; Singh, B.; Elliott, J.F.; Serreze, D.V.; and Leiter, E.K.: Quantitative Thresholds of MHC Class II I-E Expressed on Hematopoietically Derived APC in Transgenic NOD/Lt Mice Determine Levels of Diabetes Resistance and Indicate Mechanism of Protection. The Journal of Immunology 157, 1996, pp. 1279-1287. 
  40. *Bowman, M.A.; Simell, O.G.; Peck, A.B.; Cornelius, J.; Luchetta, R.; Look, Z.; Maclaren, N.K.; and Atkinson, M.A.: Pharmacokinetics of Aminoguanidine Administration and Effects on the Diabetes Frequency in Nonobese Diabetic Mice.  The Journal of Pharmacology and Experimental Therapeutics 279, 1996, pp. 790-794.
  41. *Maclaren, N.K.; and Atkinson, M.A.:  Insulin-Dependent Diabetes Mellitus:  the Hypothesis of Molecular Mimicry Between Islet Cell Antigens and Microorganisms. Molecular Medicine 3, 1997, pp. 76-83.
  42. *Atkinson, M.A.: Diet, Genetics, and Diabetes: The Role of Infant Nutrition in the Pathogenesis of Insulin Dependent Diabetes.  Food Technology 51, 1997, pp. 77-79.
  43. *Cetkovic-Cvrlje, M.; Gerling, I.C.; Muir, A.; Atkinson, M.A.; Elliot, J.F.; Leiter, E.H.:  Amelioration or Acceleration of Diabetes in NOD/Lt Mice Mediated by Intrathymic Administration of Candidate Beta Cell Autoantigens. Diabetes 46, 1997, pp. 1975-1983.
  44. *Tian, J.; Clare-Salzler, M.C.; Herschenfeld, A.; Middleton, B.; Newman, D.; Evans, C.; Atkinson, M.A.; Mueller, R.; Mullen, Y.; Sarvetnick, N.; Tobin, A.J.; and Kaufman, D.L.: Glutamate Decarboxylase Administration Inhibits Disease Progression in Prediabetic Mice and Prolongs Survival of Transplanted Islets in Diabetic Mice.  Nature Medicine 2, 1996, pp. 1348-1353.
  45. *Atkinson, M.A.; Gendreau, P.; Rinker, C.; Ellis, T.; and Petitto, J.: NOD Mice as a Model for Inherited Deafness. Diabetologia 56, 1997, pp. 501-502.
  46. *Atkinson, M.A.; and Ellis, T.M.: Infant Diets and Insulin Dependent Diabetes: Evaluating the “Cows Milk Hypothesis” and a Role for anti-Bovine Serum Albumin Immunity. Journal of the  American College of Nutrition 16 , 1997, pp. 334-340.
  47. *Atkinson, M.A.: Molecular Mimicry and the Pathogenesis of Insulin Dependent Diabetes Mellitus: Still Just an Attractive Hypothesis. Annals of  Medicine 29, 1997, pp. 76-84.
  48. *Ellis, T.M.; Hardt, N.S.; and Atkinson, M.A.: Cellular Immune Activities in Women with Silicone Breast Implants. Annals of  Allergy, Asthma, & Immunology 79, 1997, pp. 151-154. 
  49. Atkinson, M.A.: Mechanisms Underlying the Loss of Self-Tolerance in NOD Mice. Research in Immunology 148, 1997, pp. 301-307.
  50. *Wilson, S.B.; Kent, S.C.; Patton, K.T.; Orban, T.; Jackson, R.A.; Exley, M.; Porcelli, S.; Schatz, D.A.; Atkinson, M.A.; Balk, S.P.; Strominger, J.L.; Hafler, D.A.: Extreme Th1 Bias of Invariant Va24JaQ T cells in Type 1 Diabetes. Nature 391, 1998, pp.1348-1353. 
  51. *Zechel, M.A.; Elliott, J.F.; Atkinson, M.A.; Singh, B.: Characterization of Novel T-cell Epitopes on 65 kDa and 67 kDa Glutamic Acid Decarboxylase Relevant in Autoimmune Responses in NOD Mice The Journal of  Autoimmunity 11, 1998, pp. 83-95.
  52. *Ellis, T.; Schatz, D.; Ottendorffer, E.: Wasserfall, C.; Lan, M.; Notkins, A.; Maclaren, N.; Atkinson, M.: Relationship between humoral and Cellular Immunity to IA-2 in Insulin Dependent Diabetes. Diabetes 47, 1998, pp. 566-569.
  53. *Ellis, T.; Jodoin, E.; Schatz, D.; Ottendorffer, E.: She, J.S.; Atkinson, M.: Cellular Immune Responses Against b Casein: Elevated but not Specific for Persons with Insulin Dependent Diabetes. Diabetologia 41, 1998, pp. 731-735.
  54. *Schatz, D.; Ellis, T.; Ottendorfer, E.; Jodoin, E.; Salisbury, P.; Barrett, D.; Atkinson, M.: Aging and the Immune Response to Tetanus Toxoid: Diminished Frequency and Level of Cellular Immune Reactivity to Antigenic Stimulation. Clinical Diagnostic Laboratory Immunology 5, 1998, pp. 894-896.
  55. *Song, S.; Morgan, M.; Ellis, T.; Poirer, A.; Chesnut, K.; Wang, J.; Brantly, M.; Byrne, B.J.; Atkinson, M.; Flotte, T.R.: Sustained Secretion of Human Alpha-1-Antitrypsin from Murine Muscle Transduced with Adeno-Associated Virus Vector. Proceedings of The National Academy of Sciences, USA 95, 1998, pp. 14384-14388.
  56. *Leslie, D.; Atkinson, M.A.; Notkins, A. L.: Autoantigens IA-2 and GAD in Type 1 (Insulin Dependent) Diabetes. Diabetologia 42, 1999, pp. 3-14.
  57. *Ellis, T.: Jodoin, E.; Ottendorffer, E.; Salisbury, P.; She, J.X.; Schatz, D.; Atkinson, M.A.: Cellular Immune Activities against proinsulin: No Evidence for Enhanced Reactivity in Individuals with Insulin Dependent Diabetes Mellitus. Diabetes 48, 1999, pp. 299-303.
  58. Wilson, S.B.; Kent, S.C.; Patton, K.T.; Orban, T.; Jackson, R.A.; Exley, M.; Porcelli, S.; Schatz, D.A.; Atkinson, M.A.; Balk, S.P.; Strominger, J.L.; Hafler, D.A.: Extreme Th1 Bias of Invariant Va24JaQ T cells in Type 1 Diabetes. Nature 399, 1999, pp. 84.
  59. *Falta, M.T.; Magin, G.K.; Allegretta, M.; Steinman, L.; Atkinson, M.A.; Brostoff, S.W.; Albertini, R.: Selection of hprt Mutant T Cells as Surrogates for Dividing Cells Reveals a Restricted T Cell Receptor BV Repertoire in Insulin-Dependent Diabetes Mellitus. Clinical Immunology 90, pp. 340-351, 1999.
  60. *Atkinson, M.A.; Leiter, E.H.: The NOD Mouse Model of Type 1 Diabetes Mellitus: Too Much of a Good Thing? Nature Medicine 5, pp. 601-604, 1999.
  61. *She, J.S.; Ellis, T.; Wilson, B.; Wasserfal, E.; Kent, S.; Hafler, D.; Schatz, D.; Muir, A.M.; Strominger, J.;  Atkinson, M.: Heterophile Antibodies Segregate in Families and are Associated with Protection from Type 1 Diabetes. Proceedings of The National Academy of Sciences, USA 96, pp. 8116-8119, 1999.
  62. *Ottendorfer, E.; Ellis, T.M.; Bahjat, K.S.; Clare-Salzler, M.;  Atkinson. M.A.: No Alteration in T Lymphocyte Expression of CD40 Ligand (CD154) in Individuals with or at Increased Risk for Insulin-Dependent Diabetes Mellitus. The Journal of Clinical Endocrinology and Metabolism  84, pp. 4068-4072, 1999.
  63. *Roep, B.O., Atkinson, M.A.; van Endert, P.M.; Gottlieb, P.A.; Wilson, .B.; and Sachs, J.A.; for the workshop participants: Autoreactive T-cell Responses in Insulin-Dependent (Type 1) Diabetes Mellitus: Report of the First International Workshop for Standardization of T-cell Assays. The Journal of Autoimmunity 13, pp. 267-282, 1999. 
  64. *Atkinson, M.A.; Ellis, T.M.; Serreze, D.V.: Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in b Cells. Science 287, pp. 191-192, 2000. 
  65. *Wasserfall, C.; Atkinson, M.; Jodoin, E.; Schatz, D.; She, J.X.; Ellis, T.M.: Glutamic Acid Decarboxylase and IA-2 Autoantibodies in Type 1 Diabetes; Comparing Sample Substrates for Autoantibody Determination.  Pediatric Diabetes 1: 10-16, 2000. 
  66. *Serreze, D.; Ottendorfer, E.; Gauntt, C.; Ellis, T.M.; Atkinson, M.A.: Acceleration of Insulin Dependent Diabetes Mellitus by a Coxsackievirus Infection Requires a Preexisting Critical Mass of Autoreactive T cells in Pancreatic Islets. Diabetes 49: 708-711, 2000.
  67. *Atkinson, M.; Honeyman, M.; Peakman, M.; Roep, B.: Standardization of T Cell Assays in Type 1 Diabetes Diabetologia 43: 819-20, 2000.
  68. *M. T. Falta, M. A. Atkinson, M. Allegretta, P. M. Vacek and R. J. Albertini. Azathioprine Associated T-Cell Mutations in Insulin-Dependent Diabetes Mellitus. Scandinavian Journal of Immunology  51: 626-634, 2000.
  69. Atkinson, M.: The $64,000 Question in Diabetes Continues. The Lancet  356: 4-6, 2000.
  70. Haskins, K.: Atkinson, M.: Predicting Disease in Animal Models of Type 1 Diabetes: Lessons for Studies of Humans?  J. Autoimmunity 16: 15-19, 2001.
  71. *Flotte, T.; Song, S.; Wang, J.; Chesnut, K.; Wasserfall, C.; Kapturczak, M.; Ellis, T,; Agarwal, A.; Nick, H,; Atkinson: Efficient Ex Vivo Transduction of Pancreatic Islet Cells with Recombinant Adeno-Associated Virus Vectors. Diabetes 50: 515-20, 2001. 
  72. *Bingley, P.J.; Bonifacio, E.; Ziegler, A.G.; Schatz, D.; Atkinson, M.; Eisenbarth, G.: Proposed Guidelines on Screening for Risk of Type 1 Diabetes.  Diabetes Care 24: 398, 2001.
  73. *Kapturczak, M.H.; Flotte, T.R.; Atkinson, M.A.: Adeno-Associated Virus (AAV) as a Vehicle for Therapeutic Gene Delivery:  Improvements in Vector Design and Viral Production Enhance Potential to Prolong Graft Survival in Pancreatic Islet Cell Transplantation for the Reversal of Type 1 Diabetes. Current  Molecular Medicine 1: 245-258, 2001.
  74. *Tisch, R.; Wang, B.; Atkinson, M.A.; Serreze, D.V.; Friedline, R.: A Glutamic Acid Decarboxylase 65-Specific Th2 Cell Clone Immunoregulates Autoimmune Diabetes in Nonobese Diabetic Mice. The Journal of  Immunology  166: 6925-6936, 2001. 
  75. *Atkinson, M.; Eisenbarth, G.: Type 1 Diabetes: New Perspectives on Disease Pathogenesis and Treatment. The Lancet  358: 221-229, 2001.
  76. *Goudy, K.; Song, S.; Wasserfall, C.; Zhang, Y.C.; Kapturczak, M.; Muir, A.; Powers, M.; Scott-Jorgensen, M.; Campbell-Thompson, M.; Crawford, J.M.; Ellis, T.M.; Flotte, T.R.; Atkinson, M.A.:  Adeno-Associated Virus Vector Mediated Interleukin-10 Gene Delivery Prevents Type 1 Diabetes in NOD Mice. Proceedings of The National Academy of Sciences, USA. 98: 13913-13918, 2001.
  77. *Peakman, M.; Tree, T.I.; Endl, J.; Endert, P.V.; Atkinson, M.A.; Roep, B.O.;Characterization of Preparations of Glutamic Acid Decarboxylase-65, Proinsulin and the Islet Tyrosine Phosphatase IA-2 for Use in Detection of Autoreactive T Cells in Type 1 Diabetes Mellitus. Report of Phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T cell Assays in Type 1 Diabetes Mellitus. Diabetes 50:: 1749-54, 2001.
  78. *Bonifacio, E.; Atkinson, M.A.; Eisenbarth, G.S.; Kay, T.W.H.; Serreze, D.V.; Chan, E.L.; Singh, B.L.: International Workshop on Lessons from Animal Models for Human Type 1 Diabetes: Identification of Insulin but not Glutamic Acid Decarboxylase or IA-2 as Specific Autoantigens of Humoral Autoimmunity in Nonobese Diabetic Mice. Diabetes  50:2451-2458, 2001.
  79. *Brod, S.A.; Orlander, P.R.; Lavia, V.R.; Brosnan, P.G.; Hardin, D.S.; Hanninger, E.; Atkinson, M.A., Riley, W.J.: Ingested IFN-alpha prolongs the “Honeymoon” Period in Newly-Diagnosed Type 1 Diabetes Mellitus. Journal of Interferon and Cytokine Research 21:1021-1031, 2001. 
  80. *Kapturczak, M.; Zolotukhin, S.;Cross, J.:Powers, M.; Jehle, K.: Inverardi, L.;  Pileggi, A.; Flotte, T.R.; Nick, H.; Atkinson, M.; Agarwal, A.:  Transduction of Human and Murine Pancreatic Islet Cells Using a Bicistronic Recombinant Adeno-Associated Viral Vector. Molecular Therapy  5: 154-160, 2002. 
  81. Bonifacio, E.; Atkinson, M.; Eisenbarth, G.; Serreze, D.; Kay, T.W.H.; Lee-Chan, E.; Singh, B.: International Workshop on Lessons from Animal Models for Human Type 1 Diabetes: Analyzing Target Autoantigens of Humoral Immunity in Non-Obese Diabetic Mice. Annals New York Academy of Sciences  958:1-2.

         Return to:  Top of page | Dr. Atkinson's home page